First-line treatment for nonalcoholic fatty liver disease (NAFLD) focuses on weight loss through lifestyle modifications.¹,² Weight loss ≥5% results in reduction of steatosis and weight loss ≥10% has been associated with improvement in hepatic inflammation and fibrosis.³ The incidence and sustainability of weight loss among patients with NAFLD were estimated and associating factors identified.
No takes yet. Share an insight, caveat, or question.
Malespin et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: